Quest Diagnostics (DGX) Consolidated Net Income (2017 - 2025)
Historic Consolidated Net Income for Quest Diagnostics (DGX) over the last 13 years, with Q3 2025 value amounting to $251.0 million.
- Quest Diagnostics' Consolidated Net Income rose 865.8% to $251.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $986.0 million, marking a year-over-year increase of 1359.45%. This contributed to the annual value of $902.0 million for FY2024, which is 226.76% up from last year.
- According to the latest figures from Q3 2025, Quest Diagnostics' Consolidated Net Income is $251.0 million, which was up 865.8% from $287.0 million recorded in Q2 2025.
- Quest Diagnostics' Consolidated Net Income's 5-year high stood at $640.0 million during Q2 2021, with a 5-year trough of $113.0 million in Q4 2022.
- Its 5-year average for Consolidated Net Income is $290.1 million, with a median of $242.0 million in 2023.
- As far as peak fluctuations go, Quest Diagnostics' Consolidated Net Income crashed by 7087.63% in 2022, and later surged by 7433.63% in 2023.
- Over the past 5 years, Quest Diagnostics' Consolidated Net Income (Quarter) stood at $388.0 million in 2021, then tumbled by 70.88% to $113.0 million in 2022, then surged by 74.34% to $197.0 million in 2023, then grew by 17.26% to $231.0 million in 2024, then grew by 8.66% to $251.0 million in 2025.
- Its Consolidated Net Income was $251.0 million in Q3 2025, compared to $287.0 million in Q2 2025 and $217.0 million in Q1 2025.